About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Cost Efficacy Evaluation of Robot Assisted Radical Prostatectomy

Cost Efficacy Evaluation of Robot Assisted Radical Prostatectomy

NCT02784314·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospices Civils de Lyon

Age

40–70

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Localized prostate cancer
Gleason grade ≤ 3 + 4
PSA \< 15 ng / mL
Stage ≤ T2b
Eligible to receive laparoscopic radical prostatectomy
Candidate bilateral or unilateral erectile preservation

You may not be if

Patient at high risk of postoperative progression (PSA\> 15 ng / mL; grade 5 predominant, clinical or radiological stage T3
Presenting erectile dysfunction (IIEF \< 22)
Past history of urinary incontinence (\> grade 1 WHO)
Body mass index \> 30

The record

StatusCompleted

PhaseNo phase

Taking part25

StartedMay 2010

UpdatedJun 5, 2017

Conditions

Prostate Cancer

Where3

Service d'Urologie - Clinique St Augustin
Bordeaux, France
Service d'Urologie et Chirurgie de la Transplantation - Hôpital Edouard Herriot -Hospices Civils de Lyon
Lyon, France
Service d'Urologie - Institut Mutualiste Montsouris
Paris, France